Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TNFSF18 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
WNT6 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
UBE2K - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LDLRAD4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SRPK2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
OLIG2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SMARCA1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ARL1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
FCF1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
UGP2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GRSF1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SRRT - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CPD - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
KIN - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TRIT1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
EGR3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SH2D3A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HUNK - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
FCHSD2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PRR5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on